|
RNF44 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.001600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.760600E-03 |
| Normal-vs-Stage2 |
2.507500E-02 |
| Normal-vs-Stage3 |
9.91169999999819E-05 |
| Normal-vs-Stage4 |
1.596870E-03 |
| Stage1-vs-Stage2 |
9.916600E-01 |
| Stage1-vs-Stage3 |
2.746500E-02 |
| Stage1-vs-Stage4 |
2.825400E-01 |
| Stage2-vs-Stage3 |
1.434610E-01 |
| Stage2-vs-Stage4 |
3.833800E-01 |
| Stage3-vs-Stage4 |
5.699800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.875860E-03 |
| Normal-vs-AfricanAmerican |
6.284000E-02 |
| Normal-vs-Asian |
3.624000E-02 |
| Caucasian-vs-AfricanAmerican |
7.994200E-01 |
| Caucasian-vs-Asian |
4.079200E-01 |
| AfricanAmerican-vs-Asian |
7.966000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.642000E-03 |
| Normal-vs-Female |
7.390000E-04 |
| Male-vs-Female |
7.612400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.744600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.918500E-03 |
| Normal-vs-Age(61-80Yrs) |
6.163500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.020170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.250800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.256600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.940200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.853800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.643800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.775800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.408120E-04 |
| Classical-VS-Follicular |
9.359900E-03 |
| Classical-VS-Other |
2.381000E-01 |
| Classical-VS-Normal |
2.351600E-02 |
| Tall-VS-Follicular |
1.174370E-01 |
| Tall-VS-Other |
6.113200E-01 |
| Tall-VS-Normal |
1.57369999999046E-05 |
| Follicular-VS-Other |
7.672800E-01 |
| Follicular-VS-Normal |
2.407400E-04 |
| Other-VS-Normal |
3.902000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.543200E-03 |
| Normal-vs-N1 |
2.163100E-03 |
| N0-vs-N1 |
5.922800E-01 |
|
|
